Pipeline

Candidates Indication Preclinical Phase 1 Phase 2 Phase 3
ARD-101
Oral 		General Obesity
Post-Bariatric Surgery
Prader-Willi Syndrome
ARD-301
Oral 		Fibromyalgia
ARD-380
Oral 		Overactive Bladder
ARD-501
Oral 		Autism
ARD-701
Topical 		Inflammatory Skin Disorder
ARD-101 Oral
General Obesity
Phase 2
Post-Bariatric Surgery
Phase 2
Prader-Willi Syndrome
Phase 2
ARD-301 Oral
Fibromyalgia
Phase 2 (Partnered with Scilex Pharmaceuticals)
ARD-380 Oral
Overactive Bladder
Preclinical
ARD-501 Oral
Autism
Phase 1
ARD-701 Topical
Inflammatory Skin Disorder
Preclinical